Buy Us a Cup of Coffee

Teleflex Convenes Urologists in Australia for Summit on Treating Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms

Teleflex Convenes Urologists in Australia for Summit on Treating Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
Minimally Invasive UroLift® System Provides Safe and Effective Symptom Relief for Men with an Enlarged Prostate While Preserving Sexual Function*

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) recently hosted urologists from around the world to review clinical data and share best practices for using the UroLift® System to improve the care of patients with an enlarged prostate, or benign prostatic hyperplasia (BPH).

Throughout the day-and-a-half Inaugural ANZ BPH Summit, held at the Pullman Sydney Airport Hotel Nov. 15-16, attendees learned about the advancement of BPH treatment and the evolution of the UroLift System, reviewed clinical data, and exchanged best practices, and advanced techniques for treating BPH.

“It was fantastic to have passionate international and local urologists gather at the Inaugural ANZ BPH Summit to share their experiences, knowledge, and advancements in BPH treatment,” said Alistair McKeon, General Manager Teleflex Australia and New Zealand. “We’re very fortunate to work with such a dedicated group of physicians in shaping the future of minimally invasive BPH treatment.”

READ:  Optimizing Ventilator Use During the COVID-19 Pandemic

“The UroLift System was developed as an innovative solution for BPH that involves no cutting, heating or removal of tissue, in a simple procedure,” added co-founder Ted Lamson.

BPH, also known as an enlarged prostate, is non-cancerous enlargement of the prostate that occurs as men age. The condition affects over 680,000 men in the Australia alone. More than 40% of men in their 50s have BPH and over 80% of men in their 70s have BPH. The symptoms of BPH can cause loss of productivity, depression, and decreased quality of life.1 In addition, if left untreated the condition can worsen over time and cause permanent bladder damage.2

Source: Teleflex Incorporated, 550 E Swedesford Rd Ste 400, Wayne PA 19087
1 Speakman et al. 2014 BJU International
2 Tubaro et al. 2003 Drugs Aging
3 Roehrborn, J Urology 2013 LIFT Study
4 Shore, Can J Urol 2014 Local Study
*No instances of new, sustained erectile or ejaculatory dysfunction

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee